These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9352909

  • 21. Functional analysis of three topoisomerases that regulate DNA supercoiling levels in Chlamydia.
    Orillard E, Tan M.
    Mol Microbiol; 2016 Feb; 99(3):484-96. PubMed ID: 26447825
    [Abstract] [Full Text] [Related]

  • 22. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
    de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG.
    Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551
    [Abstract] [Full Text] [Related]

  • 23. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
    Holden JA, Wall ME, Wani MC, Manikumar G.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):66-76. PubMed ID: 10496978
    [Abstract] [Full Text] [Related]

  • 24. Characterization of topoisomerase I and II activities in nuclear extracts during callogenesis in immature embryos of Zea mays.
    Carballo M, Giné R, Santos M, Puigdomènech P.
    Plant Mol Biol; 1991 Jan 01; 16(1):59-70. PubMed ID: 1653630
    [Abstract] [Full Text] [Related]

  • 25. The HSP90 and DNA topoisomerase VI inhibitor radicicol also inhibits human type II DNA topoisomerase.
    Gadelle D, Graille M, Forterre P.
    Biochem Pharmacol; 2006 Nov 15; 72(10):1207-16. PubMed ID: 16959221
    [Abstract] [Full Text] [Related]

  • 26. A topoisomerase from Escherichia coli related to DNA gyrase.
    Brown PO, Peebles CL, Cozzarelli NR.
    Proc Natl Acad Sci U S A; 1979 Dec 15; 76(12):6110-4. PubMed ID: 230498
    [Abstract] [Full Text] [Related]

  • 27. The unique DNA topology and DNA topoisomerases of hyperthermophilic archaea.
    Forterre P, Bergerat A, Lopez-Garcia P.
    FEMS Microbiol Rev; 1996 May 15; 18(2-3):237-48. PubMed ID: 8639331
    [Abstract] [Full Text] [Related]

  • 28. Calf-thymus topoisomerase I equilibrates metastable secondary structure subsequent to relaxation of superhelical stress.
    Brewood GP, Delrow JJ, Schurr JM.
    Biochemistry; 2010 Apr 27; 49(16):3367-80. PubMed ID: 20178373
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE, Adachi K, Morgan AR.
    Mol Pharmacol; 1991 Oct 27; 40(4):495-501. PubMed ID: 1656189
    [Abstract] [Full Text] [Related]

  • 32. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P, Nagaraja V.
    Mol Microbiol; 2005 Dec 27; 58(5):1392-405. PubMed ID: 16313624
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
    Kusumoto H, Rodgers QE, Boege F, Raimondi SC, Beck WT.
    Cancer Res; 1996 Jun 01; 56(11):2573-83. PubMed ID: 8653700
    [Abstract] [Full Text] [Related]

  • 36. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
    Pruss GJ, Franco RJ, Chevalier SG, Manes SH, Drlica K.
    J Bacteriol; 1986 Oct 01; 168(1):276-82. PubMed ID: 3019999
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison.
    Godbole AA, Ahmed W, Bhat RS, Bradley EK, Ekins S, Nagaraja V.
    Biochem Biophys Res Commun; 2014 Apr 18; 446(4):916-20. PubMed ID: 24642256
    [Abstract] [Full Text] [Related]

  • 38. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F, Piñero J, Palitti F.
    Mutat Res; 1993 Aug 18; 288(2):281-9. PubMed ID: 7688089
    [Abstract] [Full Text] [Related]

  • 39. Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains.
    Sasaki T, Sasaki Y, Kita M, Suzuki K, Watanabe H, Honda M.
    J Clin Microbiol; 1992 Sep 18; 30(9):2435-40. PubMed ID: 1401012
    [Abstract] [Full Text] [Related]

  • 40. Topoisomerases I and III inhibit R-loop formation to prevent unregulated replication in the chromosomal Ter region of Escherichia coli.
    Brochu J, Vlachos-Breton É, Sutherland S, Martel M, Drolet M.
    PLoS Genet; 2018 Sep 18; 14(9):e1007668. PubMed ID: 30222737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.